文献速递前列腺癌

根治性前列腺切除术后分子切缘状态:GSTP1启动子高甲基化分析

Molecular margin status after radical prostatectomy using glutathione S-transferase P1 (GSTP1) promoter hypermethylation.
PubMed 文献 · BJU Int · 2021-11-03

该研究对254例临床局限性前列腺癌患者根治性前列腺切除术后前列腺窝活检组织进行GSTP1启动子高甲基化检测,共分析2286个活检样本,并设32例对照。结果显示13.4%患者至少一个核心阳性,GSTP1高甲基化与肿瘤分期、ISUP分级、淋巴结状态、手术切缘状态及生化复发显著相关;但经典R状态在预测复发上显著优于组织学取样,与GSTP1分析无显著差异。

要点

  • GSTP1启动子高甲基化与肿瘤分期、淋巴结状态、切缘状态及生化复发显著相关。
  • 46例(18.1%)患者经进一步分析后常规手术切缘状态发生降级或升级。
  • 经典R状态显著优于前列腺窝组织学取样(P=0.006),但与GSTP1分析无显著差异(P=0.227)。

核心结论

  • GSTP1启动子高甲基化检测对预测根治性前列腺切除术后残留肿瘤和复发有一定价值。
  • 经典R状态更简单、更广泛适用,且与GSTP1分析结果相似。

研究设计与样本

  • 分析2446个活检样本:2286个来自254例临床局限性前列腺癌根治性前列腺切除术患者,160个来自32例对照组患者。
  • 术后从前列腺窝特定区域获取活检组织,进行组织病理学和分子遗传学分析,并与临床病理数据关联。

主要发现

  • 34例患者(13.4%)至少一个核心GSTP1启动子高甲基化阳性,其中6例(17.6%)为pT2/pN0,28例(82.4%)为≥pT3和/或pN1。
  • GSTP1启动子高甲基化与肿瘤分期(P<0.001)、ISUP分级(P=0.001)、淋巴结状态(P<0.001)、手术切缘状态(P<0.001)及生化复发(P=0.001)显著相关。
  • 46例患者(18.1%)经进一步分析后常规手术切缘状态发生降级或升级。
  • 经典R状态显著优于前列腺窝组织学取样(P=0.006),但与GSTP1分析无显著差异(P=0.227)。

临床怎么用

  • GSTP1启动子高甲基化分析可作为根治性前列腺切除术后预测复发的辅助分子标志物。
  • 经典R状态仍是简单且广泛适用的切缘评估方法,与GSTP1分析结果相似。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess the potential for molecular staging in biopsies of the prostatic fossa after radical prostatectomy (RP) by searching for occult tumour cells through analysis of glutathione S-transferase P1 (GSTP1) methylation status. PATIENTS AND METHODS: We analysed 2446 biopsies: 2286 biopsies from a group of 254 patients with clinically organ-confined prostate cancer who underwent RP and 160 biopsies from a control group of 32 patients. After prostate gland excision, biopsies were obtained from defined areas of the prostatic fossa and bisected for histopathological and molecular genetics analyses. Results were related to clinicopathological data including tumour stage, lymph node status, resection status, tumour grading, initial PSA level, and biochemical recurrence. RESULTS: In total, 34 patients (13.4%) had at least one core positive for the GSTP1 promoter hypermethylation, six of whom (17.6%) were characterised as having a clinically localised tumour stage (pT2, pN0) and 28 (82.4%) as an advanced tumour stage (≥pT3 and/or pN1). GSTP1 promoter hypermethylation significantly correlated with tumour stage (P < 0.001), International Society of Urological Pathology grading (P = 0.001), lymph node status (P < 0.001), surgical margin status (P < 0.001), and biochemical recurrence (P = 0.001). Furthermore, in 46 patients (18.1%) further analysis led to a down- or upgrading of conventional surgical margin status. Classical R-status (margins of the specimen) is significantly superior to histological sampling from the fossa (P = 0.006) but not to GSTP1 analysis from the fossa (P = 0.227). CONCLUSION: For the detection of residual tumour in the fossa after RP in order to better predict recurrence, molecular GSTP1 promoter hypermethylation has some value; however, the classical R-status (margins of the specimen) is simpler and more widely applicable with similar results.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Witt JH, Friedrich M, Jandrig B, et al. Molecular margin status after radical prostatectomy using glutathione S-transferase P1 (GSTP1) promoter hypermethylation. BJU Int. 2021. PMID: 34657365. doi:10.1111/bju.15618

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。